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Introduction
The long-term consequences of childhood cancer have
received increasing attention due to the growing number
of survivors over the past decades [1, 2]. In particular,
the life-long risk of adverse health and psychosocial ef-
fects for childhood cancer survivors (CCS) have been ex-
tensively described [3–5]. Only recently, studies have
focused on the socio-economic hardships of cancer sur-
vivors and their families [6–12].
CCS report higher out-of-pocket medical expenses
[13, 14], are more often uninsured [6, 13], face diffi-
culties in obtaining life insurance [15–17], and have a
higher probability of requiring social security or dis-
ability benefits [18]. These kinds of hardship are
shown to cause or potentially exacerbate physical and
psychological harms [6, 14, 19], including anxiety,
stress, and impaired sleep [20]. Conversely, some
physical, neurocognitive, and psychological late effects
may lead to hardship such as low income and finan-
cial difficulties [7, 21–23].
The challenges faced by CCS regarding access to in-
surance and social security have not been extensively ex-
amined [15, 24]. Moreover, the bulk of this research has
focused on CCS’ experiences in the United States where,
in the absence of universal health care, CCS may be
more vulnerable to such hardships [6, 13, 25, 26]. Cor-
respondingly, these findings cannot be generalized to
countries with other social security systems in place. In
Switzerland, for example, every resident must be affili-
ated to and is covered by basic health insurance [27–29].
Furthermore, compulsory disability insurance (DI) aims
to guarantee the basic needs of persons who have be-
come disabled, by paying disability benefits and/or by
providing rehabilitation measures [30–32]. In addition to
basic health insurance and DI, there are optional private
insurance schemes such as supplementary health insur-
ance (which may for instance encompass alternative
medicine or psychotherapy) and primary private insur-
ance (e.g. life insurance) [33, 34]. In Switzerland the em-
ployer partly pays accident insurance. Meaning that
individuals without employment have to finance this
themselves. This poses an additional hardship to CCS
who are more likely to be unemployed or face difficulties
to entering the workforce [10]. Navigating through this
complex system can be challenging for CSS. Although
some support services exist, such as Procap and Kinderk-
rebshilfe Schweiz [35], most of them are either not spe-
cialized in childhood cancer or the social security
system and often CCS and their families are not aware
of these services [36].
As a country with a long history of high healthcare
costs and universal coverage, Switzerland offers a valu-
able environment to explore the experiences and needs
of CCS regarding several forms of insurance such as
health, disability, and private insurance. With the grow-
ing number of CCS due to improved treatment, recog-
nizing the socio-economic hardships of CCS is crucial.
Effective strategies that meet CCS’ needs are central to
tackle financial barriers and challenges that CCS face
during their long-term survivorship. Currently, follow-
up care for CCS is reportedly lacking psychosocial sup-
port at many pediatric oncology centers despite its
health economic relevance [36–38]. Therefore, this study
aimed to qualitatively assess the experiences and needs
of CCS living in Switzerland with a special focus on
hardships related to insurance. This assessment is fur-
ther complemented by an exploration of the views of a




This study builds on a larger mixed-methods project on
the impact of cancer and unmet needs of CCS during
survivorship, which combined a quantitative and qualita-
tive design [38]. In the current study, we used a qualita-
tive research approach [39] and conducted semi-
structured interviews with a subset of CCS from a cross-
sectional survey and insurance and legal experts.
Sample and procedure
CCS had been identified through Childhood Cancer
Switzerland, the umbrella organization of institutions in
pediatric oncology in Switzerland. Participants were eli-
gible if they were aged ≥ 18 years at time of study, diag-
nosed with cancer ≤ 18 years of age, completed
treatment ≥ 2 years before study, were Swiss residents,
and spoke German or English.
Childhood Cancer Switzerland sent an e-mail invita-
tion to participate in the cross-sectional survey to all
registered survivors (n = 132). After two months, a re-
minder was sent to non-responders. Additional partici-
pants were invited through an open electronic link that
was circulated among Swiss CCS’ networks on social
media platforms such as Twitter, and survivors’ messa-
ging services on Whatsapp as well as survivor physical
meetings. Participants completed the cross-sectional sur-
vey during which they were invited to participate in an
interview to obtain a more nuanced understanding of
their experiences, preferences and needs regarding their
long-term survivorship. After initial analysis of inter-
views with CCS, we also recruited three experts (one
legal expert, two insurance experts) by means of purpos-
ive sampling. Experts were identified through Childhood
Cancer Switzerland to explore the challenges and bar-
riers to support services for insurance hardship raised by
CCS in the interviews from experts’ view.
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Ethical approval
The study was approved by the Ethics Committee North-
west and Central Switzerland (Study-ID: EKNZ 2017-
01758). Before the interviews, participants received written
and oral information about the study. They were ensured
anonymity and provided informed consent. The project
was conducted in line with the Helsinki declaration.
Data collection
Survey participants who showed interest in participating in
the interviews shared their contact information with the study
team. Interviews were scheduled at a place of their choice (the
participants’ home, workplace, or private meeting room at a
Swiss University). The interviews were carried out until theor-
etical saturation was achieved [39]. All interviews were con-
ducted between November 2017 and February 2019. Data
were collected using a semi-structured interview guide devel-
oped by the study investigators (MH and GM). The interview
guide focused on CCS’ experiences of their childhood cancer
and survivorship [38]. Some CCS showed photographs, diar-
ies, and other memories of their cancer and survivorship ex-
perience. CCS’ experiences further informed the interview
guides for expert interviews, which entailed open questions re-
lated to the Swiss healthcare system. The audio-recorded in-
terviews lasted between 39 and 117 min (89 min on average)
and were transcribed verbatim by a transcriptionist.
Data analysis
Analysis was conducted in the form of qualitative con-
tent analysis. Two members of the research team (MJH
and EH) reviewed the transcripts to identify emerging
themes and developed a coding structure guided by
Kuckartz’s approach to content analysis [40–42]. This
approach integrates elements from grounded theory
such as theoretical memos and iteration to generate not
only descriptive results but also conceptual models of
the topics under study. First, the initial coding structure
was developed based on our research question, interview
guide, and reviewed literature (MH, EH). Second, pre-
liminary codes were generated through systematic cod-
ing of the data by first and second author. Then
identified codes were reviewed and refined. Consensus
for coding was reached dialogically among the two au-
thors. All transcripts were re-coded at the end of the
process using the finalized coding structure. Qualitative




Of the 69 respondents of the previously administered
survey [38], 51 expressed interest to further participate
in the interview study. Subsequently approached by the
study team, 21 individuals did not reply, one declined
participation, and two could not find the time to make
an appointment. We conducted interviews with the
remaining 28 participants (response rate 55 %). Among
them, the most frequently reported diagnosis was
leukemia (10/28). Survivors had completed treatment on
average 19 years prior. Of the 28 participants, 68 % were
female (mean age at study: 31 years; mean age at diagno-
sis: 9 years; Table 1). All interviewed experts (one legal,
two insurance experts) had >25 years of professional ex-
perience (Table 1).
Overall, three key themes emerged from the interviews
with the CCS: 1) experiences with insurance, 2) percep-
tion of discrimination, and 3) needs and barriers for sup-
port. The interviewed experts provided further detailed
clarification of CCS’ concerns, which are grouped to
match the themes. In the following, we describe each
theme in detail.
Experiences regarding insurance
CCS expressed concerns about the many different facets
of insurance, ranging from basic health insurance to DI
and private insurance (Table 2). As one CCS phrased it;
“What I think has stuck with me most of all are not the
physical aspects but the whole thing with the insurances.”
With regard to basic health insurance, most CCS were
satisfied with the coverage. However, some CCS also men-
tioned that they had to actively invest time and energy
into making sure they were reimbursed for their health-
care costs. CCS, who reported difficulties with their basic
health insurance, similarly pointed towards difficulties
with reimbursements. This encompassed novel treatments
such as fertility costs or rehabilitation treatment abroad
and included costs caused by dental late effects.
CCS described different concerns relating to DI, in
which CCS with late effects or disability can request to
reduce working hours. CCS who received DI or were in
the process of acquiring DI described it as a challenging
procedure. One CCS reported having to “muddle
through” the entire process for two and a half years.
Others reported they had to explain a lot and questioned
whether staff assigned to their application could “really
understand what the problem is of the whole thing [can-
cer and its late effects]”. One CCS described how he
went through a challenging time in applying for DI. He
experienced the questions posed by medical experts in
charge of approving his DI application as very stressful.
In addition, the CCS mentioned he was not allowed to
have anyone present who could support him during the
questioning. He stated that in getting his medical ap-
proval for DI, he had to go through “3 hours of almost
psycho-terror”. Or as another CCS reported: “When you
are really unstable and mentally not quite there […].
Then you are helpless, lost - really simply at their
mercy.”
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Table 1 Sample description of participants
Childhood cancer survivors







26-30 years 5 (17.9)
31-35 years 4 (14.3)
>35 years 8 (28.6)
Nationality
Swiss 24 (85.7)
Swiss and other nationality 4 (14.3)







Compulsory schooling 4 (14.3)
Vocational training 13 (46.4)
Upper secondary 6 (21.4)








CNS tumor 3 (10.7)
Othera 10 (35.7)
Age at diagnosis
0-5 years 7 (25.0)
6-11 years 10 (35.7)
12-18 years 11 (39.3)
Treatment
Surgery only or chemotherapyb 15 (53.6)
Radiationc 10 (35.7)
Bone marrow transplantationd 3 (10.7)
Time since end of treatmente
≤5 years 3 (11.1)
6-15 years 8 (29.6)
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While some CCS were in the process of requesting DI,
others were reluctant to apply despite potentially being
qualified. Those who were currently reluctant expressed
either a negative attitude toward being a DI-recipient or
wanted to resume their normal life. Additionally, some
CCS who had been reluctant earlier, and refrained from
applying for DI, did not know how to apply for DI now,
and some faced difficulties with their application. The
interviewed experts further explained this:
Especially in the labor market it leads to a situation
in which if a person notices that they cannot work
100 % [fulltime position], because they just can’t
cope, people simply say then “I will reduce 20 % of
my workload”, but they don’t report it [to the DI]
and then they have voluntarily reduced. […] and
somehow 10 years later when they reduce again from
80 to 60 % they declare [to the DI] that this is now
because of demonstrable medical late effects of can-
cer. Only then are they considered 20 % disabled be-
cause before that they have ‘voluntarily’ reduced
their workload [from 100 % to 80 %]. In reality, they
would be 40 % disabled, but because they did not
declare the first 20 % years before, because they did
not want to admit they need DI, for understandable
reasons, they punish themselves because otherwise
Table 1 Sample description of participants (Continued)
16-25 years 6 (22.2)




Type of late effectse
Physical 12 (75.0)
Physical and psychological 4 (25.0)
Follow-up attendance
Yes 15 (53.6)








Age at study 31.4 (18-55)
Age at diagnosis 9.3 (0.5-16)
Time since end of treatment 19.1 (2-38)
Experts






Age at study 51.6 (41-56)
Working experience 26.3 (21-33)
aOther includes neuroblastoma, renal tumor, bone tumor, soft tissue sarcoma, thyroid cancer, germ cell cancer and histiocytosis
bHas not included radiation
cMay have included surgery and/or chemotherapy
dMay have included surgery, chemotherapy and/or radiation
eMissing values
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they would have DI in addition to a 60 % income. If
you then perhaps still have family obligations, it is
then simply financially tight. And then there is the
question again, do you still have to manage working
80 % pensum, because they need it financially. Then
there is a vicious circle. That is what we still experi-
ence very often. – Legal expert at a patient
organization, > 25years of working experience.
The three experts mentioned the importance of pro-
viding appropriate advice to all CCS who, due to their
late effects, may have to reduce working hours in the fu-
ture and therefore apply for DI. For this reason, CCS
must be adequately informed about the measures to be
taken, which requires legal information.
In the context of private insurance, CCS reported diffi-
culties with supplementary health insurance or life
insurance. CCS who did not already have supplementary
health insurance before childhood cancer were only eli-
gible for insurance that was not related to their cancer
diagnosis or its late effects. In situations where they had
supplementary insurance prior to their childhood cancer,
they were often no longer able to make changes to their
insurance policy. CCS reported similar concerns with
their life insurance either it would not make financial
sense; premiums would be higher and/or cancer would
be excluded. Only few CCS reported no problems at all
in getting private insurance despite their childhood can-
cer history. One CCS was not requested to report his
medical history, although this is a standard and legal
procedure of insurance companies for supplementary
health and life insurance. According to him, his “insur-
ance broker at the time, [who] also had had cancer and
everything. Yeah, […] he said you should let that [the




Male survivor, >25 years since
treatment (2M)
Once, I had to make my scar more beautiful, and the […] health insurance would only finance
the cheapest [treatments], but otherwise I never had problems, I just could not change the
supplementary [health] insurance, but otherwise they [health insurance] were very
accommodating.
Female survivor, 6-15 years since
treatment (5F)
A while ago, I had broken a tooth because of the radiation. [...] They wanted to do a dental
crown, which costs a lot of money, and the health insurance said they won't pay. [...] Because
they say it can't be because of the radiation. Now I am covered by the legal insurance of my
parents, with a lawyer backing it up, now we are suing the health insurance so that they have to
pay for the tooth. I have all the documents from the radiation – from the dentist, my ENT
specialist and from the radiation. It really happened and it's not my fault. It was actually expected
that these problems would already arise 5 years ago, because they often break after 5 years, but I
took care of my teeth too well. Brushing my teeth too well. And seeing as it is only happening
now, in their opinion, it is too late now. In their point of view there can’t be any connection
because it is too long ago. And well my ENT specialist says, because she took such good care of
it, it's 5 years later; "Don't be stupid, just pay for it." Yes, yes, and by law they should pay. Health
insurance article 19, ((laughs)) I have learned that, yes, I also had a meeting with the lawyer who
is looking into it, and he said they have to pay.
Disability
insurance
Female survivor, 16-25 years
since treatment (16F)
[after finding a late effect] my doctor also thought that we should clarify about applying for DI
and so on, and I said right away that I didn't want to, because there are enough DI recipients
who shouldn't be, where it's actually not justified [...] I don't feel as if I'm entitled to demand
something like that, because I can work 100%, I've been in this profession for two and a half
years now after my apprenticeship, and yes, I never had the feeling that I needed or wanted it.
Female survivor, 6-15 years since
treatment (27F)
I know I was once told I could get DI if I wanted to. I missed jumping on that train because I just
thought, no, I'm doing very well. There are people who really need it, who have to get DI and
now I have been thinking, why didn't I do that back then and just seize this opportunity. Not to
exploit, not at all, but more like, then I could have looked more after, a little better after my
health. But now it's like this and it's going well, so now I have the feeling that I don't need to




Female survivor, >25 years since
treatment (22F)
But I realize now, just like that, other life insurance policies or even occupational insurance or
[supplementary] health insurance, which I have taken out because of my job, that there are
simply restrictions everywhere. Even the best insurance agent can't fix more than that. They just
say like, […] if you have this and that, then they don't pay it, they only pay for broken legs,
broken arms, but if I have anything like that with blood, they don't pay anything. Interviewer:
even if it was how many years ago, actually? Participant: Yes it is stupid, it was at the age of five
and a half and so 31 years [later]. No, they do not pay it.
Male survivor, 6-15 years since
treatment (4M)
I mean she [insurance broker] knew that I had had this, but she also knew that I am healthy and
that I will not have a relapse. Well they say, after ten years, they say, you are healthy so you are
completely cured. In fact, you will not relapse anymore and because of that you can indicate it
[disease history] without hesitation. Then you no longer have to declare it […] and you can
change [supplementary health insurance] freely.
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cancer] rest at some point.” Another CCS described how
he was able to get supplementary health insurance 10
years after being curatively treated and while attending
follow-up care.
Perception towards discrimination
In some CCS, their social and health insurance experi-
ences evoked feelings of “discrimination” and “unfair-
ness”. CCS claimed that because their cancer history is
not a lifestyle choice, when their health insurance ex-
cludes them from supplementary insurance, it feels as if
they are punished for something that is beyond their ac-
countability. One CCS mentioned that “if that happens
on the basis of the illness, […] that’s not fair, because in
most cases you cannot help it.” Another CCS said that
“Leukemia, that’s something that can happen to anyone
[…], but that’s the way the system works, I don’t think it’s
any use getting worked up about it.” Some CCS argued
that it would be different if people are excluded who can
be held accountable for their behavior (e.g. due to smok-
ing or risky sport behaviors).
Sure if someone smokes for 40 years and then sud-
denly, yes […]. But some people have been smoking
for 40 years and they don’t have such effects, but
that’s the way it is with insurance companies. If you
do risky sports, at some point someone found out
what risky sports are. Of course, I can never have a
riding accident if I don’t go riding, simple, yes. But
in case of illness, nobody knows that. That’s why I
think it’s not good to be classified that way. And
somehow you get a feeling that you are less valuable
because you had that illness, so yes, not nice – Male
survivor, > 25 years since treatment (19 M).
Need and barriers for support
CCS expressed a strong need for legal support for them-
selves and their families or parents whose children are
diagnosed with cancer. CCS further specifically wished
for a point of contact to turn to for legal questions and/
or concerns regarding insurance such as health, disabil-
ity, and private insurance. CCS acknowledged that ad-
dressing these topics or concerns would go beyond
healthcare professionals’ expertise, but they wished
someone would be able to guide them through insurance
issues.
Most CCS described how, in the end, they got legal
help through their personal contacts (i.e. parents, spouse
or social network). One CCS explained how her parents’
legal insurance had allowed her to contest the unwilling-
ness of her basic health insurance to cover a dental pro-
cedure which became necessary due to a late effect.
Without the legal insurance of her parents, she would
have had to pay the procedure herself. In addition,
without the support of a legal service the problems faced
by CCS are extremely time consuming. CCS shared stor-
ies on how they would not contest some denied reim-
bursement claims since they “do not want to get into the
whole thing and get into such a feud.”
I have to advise everyone to get a lawyer. […] I think
that, if only there was a place where I could have
gotten specific advice on this […], or a lawyer spe-
cialized in this. […] Now in the end I asked my god-
parents; they are both lawyers. Now after this I have
to say: As long as someone who had cancer can still
prove what their late effects are, and that is why
they cannot work fulltime, and they can really prove
it comes from the, for example, chemotherapy […] I
have to recommend everyone to get a lawyer. – Male
survivor, >25 years since treatment (3M)
Finally, the interviewed experts emphasized the in-
creasing need for interdisciplinary support on socio-
economic aspects during CCS’ follow-up. Although they
agreed that their recommendations would not substitute
any medical advice, they argued that, for the same rea-
son, healthcare professionals should not make “legal, so-
cial insurance, or employment law ‘diagnoses’”. This was
partly motivated by the fact that, in some circumstances,
such extra-medical advice by health professionals led to
inaccurate information provided to the CCS. Experts re-
ported that it can be incredibly difficult to correct legal
misinformation when it is provided to the CCS by
healthcare professionals;
When the client [CCS] tells me, yes, but the doctor
has said that it [the second wheelchair] will be reim-
bursed. Then I say the doctor can’t promise this as
he’s not competent to do so. It’s just going to confuse
the client. Should they believe the doctor or the law-
yer because one is ‘lying’, I find this a pity. – Legal
expert at a patient organization, > 25years of work-
ing experience.
Experts further mentioned the lack of a well-
functioning network between healthcare professionals
and interdisciplinary staff (i.e. social workers, (social) in-
surance and/or legal experts) as a primary barrier to ap-
propriately refer CCS with needs to available support
services. However, experts reported that recently both,
experts and heads of pediatric oncology departments,
are recognizing the need for interdisciplinary collabor-
ation. One center has started to invite a legal expert to a
monthly consultation hour for families, patients and sur-
vivors. With better collaboration between experts and
healthcare professionals, experts are convinced that it
will not necessarily increase demand. Instead it will
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enable better advice, less miscommunication for those
CCS vulnerable to socio-economic hardship, and more
awareness among healthcare professionals regarding the
socio-economic or legal concerns of CCS and families.
Discussion
This qualitative study has revealed several hardships
faced by CCS when managing their survivorship trajec-
tory and accessing insurance coverage. Previous research
has shown that while late effects can exacerbate hard-
ships, the hardships themselves can also cause physical
and psychosocial harm [21]. Indeed, CCS in our study
have reported that hardships related to insurance are a
frequent cause of stress, need time-consuming effort,
and require interdisciplinary support. These findings
suggest that insurance providers and regulators should
devote more attention to preventing and mitigating such
hardships. Although the Swiss social security system can
alleviate the financial burdens for some CCS through,
for example, disability benefits [30, 34], structural chal-
lenges and social restraint might hinder access to these
services.
Adequate information and collaboration to combat
information gaps
From a societal perspective, our study raises the ques-
tion of adequately informing CCS and their families
about DI, since many CCS expressed a negative attitude
towards DI and described it as something to be avoided.
This is nothing new. It is known that applying for sick-
related benefits is often connected to feelings of stigma
or insecurity due to the strong desire to be financially
self-sufficient [43]. In addition, studies have shown that
making insurance claims involves extensive workload
and psychological stress [32, 44], which might hinder
CCS from making such claims. This stands in stark con-
trast to how DI recipients are often portrayed in media
and social discourse [45]. While recognized in qualitative
research [32, 46], such negative accounts of patients’ lived
experience with DI are largely absent from public dis-
course. Albeit it is important to note that CCS with severe
neurocognitive effects of treatment whom require DI from
the time of treatment completion (e.g. brain tumor survi-
vors) are more likely to enroll or to be enrolled by their
parents and caregivers [47, 48]. However, our study indi-
cates that CCS who could benefit from some form of DI,
might nonetheless refrain from doing so due to the nega-
tive attitude towards DI. This is confirmed by studies
showing that many survivors, when categorized as ‘cured’
from cancer, wish to live everyday life without being
reminded of their past and marked with a stigma [15].
Therefore, CCS’ hesitancy to apply for DI might be related
to defense mechanisms to reduce anxiety arising from
psychologically harmful reminiscences [32]. Most
importantly, such attitudes may be strongly intertwined
with questions of personal identity, in particular to the
self-perception of the CSS and their transition from a
patient-based to a survivor-based perspective. Although
much has been written about this identity paradox when
moving from a “cancer identity” to a “survivorship iden-
tity” [49], little is known about how CCS’ may tend to re-
negotiate their identity when placing themselves on the
(dis)ability scale for their occupation.
From a structural perspective, this study shows that
CCS in Switzerland may lack adequate information,
knowledge, and support regarding insurance issues dur-
ing their survivorship trajectory. These findings suggest
that more legal support is needed for CCS and their
families. This need for information on legal and insur-
ance issues has recently been recognized by childhood
cancer patient organizations in Switzerland, which have
started to offer more services, e.g. information-weekends
on this topic for parents of CCS [50]. An improved de-
velopment of such services is required as is building
awareness among healthcare professionals on socio-
economic or legal concerns and the benefits of interdis-
ciplinary exchange and networking with legal experts
and social workers. In addition, better collaboration be-
tween these actors could support and guide CCS and
their families through the administrative and insurance
hardships they may face now or in the future. Although
medical and social issues are understandably at the fore-
front of concern for CCS and their families, it is crucial
that healthcare professionals raise the topic of socio-
economic and insurance issues to CCS and their parents
early on. By doing so, CCS and their parents will be able
to gather information on socio-economic topics and
thereby request and receive support early into survivor-
ship. Intervention and legal support from specialists with
knowledge on childhood cancer and legal proceedings
can further prevent misunderstandings between health-
care professionals and CCS. It will additionally help to
prevent CCS from making preventable mistakes in the
administrative and insurance aspects of the social secur-
ity system [51].
The right to be forgotten
Furthermore, as many CCS in our study mentioned be-
ing excluded – in some way – from private insurance
the scope and justification of insurance exclusions re-
quire greater attention. In Switzerland, apart from basic
insurance, it is generally obligatory for insurance candi-
dates to declare their medical history to most private in-
surances (such a supplementary health insurance or life
insurance). This includes someone’s cancer history.
Based on the medical history, the insurer is legally enti-
tled to impose higher premiums (increasing the cost of
insurance), limit the insurance policy by excluding some
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risks (including late effects from cancer and its treat-
ment), or even refuse insurance. Failure to disclose the
complete medical history can result in cancellation of
the insurance policy, even if certain experienced health-
conditions are entirely unrelated to cancer, and could
potentially result in prosecution for fraud. In
Switzerland, this dynamic has led to several legal pro-
ceedings for discrimination initiated by citizens against
insurers, none of which has been favorably judged by a
court [52]. Although it has not yet been recognized by
current case law, there is strong evidence that current
insurance policies have considerable potential for dis-
crimination on the grounds of illness or disability [53–
55]. Our findings corroborate this evidence at the level
of the CCS first-person perspective and lived experience,
revealing that many CCS felt discriminated against for
something that happened a long time ago, and without
their “fault”. Further, most CCS reported that their pri-
vate insurance policies excluded, inter alia, cancer re-
lapses or late effects. This problem is not exclusively
restricted to the Swiss social security system. In 2018,
the European organization “Youth Cancer Europe”
named financial discrimination as one of the five key
challenges needed to be addressed on a national and
European policy level [16]. More and more studies show
that CCS are excluded from mortgages and private in-
surances such as life insurance, supplementary health in-
surance or travel insurance [16, 56–58]. This results in
many CCS being discriminated against (as recipients of
unequal treatment) either via denied insurance or by
having to pay higher premiums than people without
chronic health-conditions [58]. There is growing agree-
ment among civil society organizations (e.g. patient alli-
ances) and regulators that current policies need to be
amended to mitigate the risk of discrimination for can-
cer patients in the insurance domain. For example, the
European Cancer Patient Coalition has advocated the
view that, once the cure of cancer is declared, survivors
should have the right to live their lives without being
discriminated for their cancer history [59]. Irrespective,
of how they are doing, compared to other people of
similar age and socio-demographic characteristics with
no cancer history.
In recent years, this shift of perspective has gained mo-
mentum among policy makers in several European
countries. In 2016, France first introduced the “Right to
be forgotten” law, which grants cancer survivors the
legal right not to disclose their cancer diagnosis to in-
surers after a period of 10 years after end of treatment,
or for cancers occurring before the age of 18 years, or 5
years after end of treatment [59, 60]. With the imple-
mentation of the European Union’s General Data Pro-
tection Regulation (GDPR), the right to be forgotten has
been enshrined in federal data protection regulation,
enabling individuals to request the deletion or removal
of specific personal data (including health data) where
there is no compelling reason for its continued process-
ing (Art. 17) [61]. Thereby the GDPR provides the lawful
basis and legal framework for enabling CCS to have their
data erased or rectified by the data controller (e.g. the
insurance provider). Also, at the European Union level,
the right to be forgotten for cancer patients has been in-
cluded in the ‘Europe’s Beating Cancer Plan’ revealed by
the European Commission in early 2020 [62]. According
to the GDPR, however, a CCS’ right to be forgotten can
be overridden by a health insurer’s right to process
someone’s data when the data represents information
that serves the public interest or is deemed necessary for
statistical or public health purposes [61].
For this reason, national derogations are necessary to
determine the conditions of applicability of the right to
be forgotten, leading countries like France to make ex-
plicitly inclusive provisions for CCS in their national le-
gislation. Belgium, The Netherlands, and Luxembourg
have since followed the French approach and adopted
similar national laws to protect cancer survivors [63].
Besides data protection, attempts to reduce discrimin-
ation have also occurred in the context of the health
law. For example, the 2010 ‘Affordable Care Act’ in the
United States entails provisions forcing insurers to
accept all applicants without charging based on pre-
existing conditions [64].
Limitations and strengths
Our study has several limitations and strengths. One
limitation is the risk of self-selection since some CCS
may have been more reluctant to participate in the study
[39], a typical limitation of qualitative approaches. Fur-
thermore, despite self-reported unmet needs, CCS might
have received additional psychosocial or socio-economic
support, but forgotten about it, or support was offered
to their parents [65]. Second, it is possible CCS who
have had negative experiences could have been more
eager to voice their issues and concerns. Third, due to
the study setting and the inherent diversity of different
national insurance systems, the findings of our study
may not be fully generalizable to other countries. How-
ever, two mitigating factors must be considered. First,
statistic-probabilistic generalizability is not inherent in
the scope of qualitative research — which is focused on
gaining a deeper understanding and uncovering deep-
rooted explanations of phenomena. Second, statistical
generalizability does not subsume generalizability tout
court, with research showing different types of
generalization such as transferability and analytical
generalizability [66].
To our knowledge, this is one of the first studies to in-
vestigate the impact of cancer survivorship within the
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Swiss healthcare system. In addition, the Swiss health-
care system shares common features with multiple inter-
national healthcare regimes, such as the French and
Italian ones. Among those, common features are, being
universal in character and entailing a basic insurance for
all. However, since there are no free state-provided
health services and private insurance is compulsory for
all residents, the Swiss system also shares commonalities
with healthcare systems largely operated by the private
sector such as the United States. For these reasons, we
believe the findings of our study can provide analytically
valuable and transferable information on the insurance-
related hardships faced by CCS. A further strength of
our study was our effort to enable CCS with severe late
effects or impairments to meet at a most comfortable lo-
cation (at work, university, library, home), hence facili-
tating their participation. In addition, the diversity of our
sample of CCS enables us to gain a multifaceted picture
of insurance hardship for CCS in Switzerland. Finally,
the combined perspectives of CCS and experts enriches
the results of our study.
Conclusion
Our findings seem to indicate that some survivors can
move past their cancer history, while others continue to
face hardships. More importantly, confusion exists about
the opportunities and services within the social security
system and most CCS relied on their personal contacts
for guidance. Hence, CCS expressed a strong need for
socio-economic and legal support for social insurance
questions, especially related to DI.
With the growing population of CCS, it is essential to
further assess the interplay between medical and psycho-
social health and socio-economic hardship. Supportive
psychosocial services should aim to ameliorate insurance
hardships. Better understanding of the relationship be-
tween childhood cancer and insurance hardship during
survivorship will inform efforts to improve long-term fi-
nancial security and health outcomes for survivors [67,
68]. Further research on insurance issues concerning
CCS and their parents, while contextualizing the Swiss
social security system, can help to establish national in-
terventions that promote family adaptation, problem
solving, coping, and resilience. Furthermore, it is neces-
sary to mitigate specific mechanisms that create financial
or other strain not only on families having experienced
childhood cancer but also families with chronically ill
children. In doing so, the perspectives of legal, health-
care, and insurance experts are essential to guide solu-
tions to the challenges and barriers reported by CCS and
their families and other vulnerable populations.
Finally, based on our study’s findings, we endorse pol-
icy reforms as the “Right to be forgotten” and call for
the public, lawmakers, researchers, insurers, and patient
organizations to come together and discuss future per-
spectives to avoid the risk of discrimination for cancer
survivors. Such public debate is critical to ensure “the
reintegration of survivors to normal social roles and ac-
tivities without discrimination” [69].
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